高額控除可能な健康保険に加入した後の糖尿病診断の遅延:コントロールによる前後研究
Felippe Ottoni Marcondes1, Fang Zhang2, Dennis Ross-Degnan2
1Division of General Internal Medicine, Massachusetts General Hospital, 100 Cambridge St, Suite 1600, 02114, Boston, MA, USA. fmarcondes@mgh.harvard.edu.
Journal of general internal medicine
|August 29, 2025
まとめ
高額控除可能な健康保険 (HDHP) は,糖尿病の診断が遅れており,医療費が増加しています. HDHPの女性はより高いリスクに直面し,診断のための自費費を削減する必要性を強調しています.
科学分野:
- 健康 経済
- 公衆衛生
- 糖尿病 研究
背景:
- 高額控除可能な健康保険 (HDHP) は,基本的医療サービスのために会員に相当な自費費 (OOP) を課します.
- これらの経済的障壁は,糖尿病を含む心臓代謝疾患の診断のタイミングに影響を与える可能性があります.
研究 の 目的:
- HDHPと糖尿病診断の遅延との関連を調査する.
- HDHP会員に対する新しい糖尿病診断に関する医療費の変化を,対照群と比較する.
主な方法:
- セグメンテッド・サバイバルとプレ・ポストをコントロールグループで設計した.
- HDHPのメンバー346,492人と,糖尿病のない18歳から64歳の対照群のデータを分析した.
- 糖尿病の診断までの時間と診断前後の医療費 (総額とOOP)
主要な成果:
- HDHPの登録は,対照群と比較して,糖尿病の診断が遅れた (1. 7 - 2.1ヶ月以上) と相関していました.
- HDHPの女性メンバーは統計的に有意な診断の遅延を示しました.
- HDHPで新たに診断された糖尿病患者は,OOPの医療費が20%増加し,OOPの医療費が51%増加しました.
結論:
- HDHPの登録は,糖尿病の診断が遅れたことと,医療費の増加と関連しています.
- HDHPのメンバーの女性は診断の遅延とコストの上昇のリスクが高いようです.
- 糖尿病診断サービスのOOPコストを減らすための政策介入は正当化されています.
関連する概念動画
Diabetes: Symptoms, Diagnosis, and Complications
685
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
685
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Carbohydrate Metabolism
11.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.7K
Dipeptidyl Peptidase 4 Inhibitors
252
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
252
Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K


